115 related articles for article (PubMed ID: 7517673)
1. Antisense src expression inhibits proliferation and erythropoietin-induced erythroid differentiation of K562 human leukemia cells.
Kitanaka A; Waki M; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
Biochem Biophys Res Commun; 1994 Jun; 201(3):1534-40. PubMed ID: 7517673
[TBL] [Abstract][Full Text] [Related]
2. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
3. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells.
Kubota Y; Tanaka T; Yamaoka G; Yamaguchi M; Ohnishi H; Kawanishi K; Takahara J; Irino S
Leukemia; 1996 Apr; 10(4):720-6. PubMed ID: 8618453
[TBL] [Abstract][Full Text] [Related]
4. Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression.
Waki M; Kitanaka A; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
Biochem Biophys Res Commun; 1994 Jun; 201(2):1001-7. PubMed ID: 7516155
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation.
Chrétien S; Varlet P; Verdier F; Gobert S; Cartron JP; Gisselbrecht S; Mayeux P; Lacombe C
EMBO J; 1996 Aug; 15(16):4174-81. PubMed ID: 8861946
[TBL] [Abstract][Full Text] [Related]
6. Control of hemoglobin synthesis in erythroid differentiating K562 cells. I. Role of iron in erythroid cell heme synthesis.
Kawasaki N; Morimoto K; Tanimoto T; Hayakawa T
Arch Biochem Biophys; 1996 Apr; 328(2):289-94. PubMed ID: 8645006
[TBL] [Abstract][Full Text] [Related]
7. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
8. Regulation of pp60c-src expression in rat and mouse fibroblasts by an inducible antisense gene: effects on serum regulation of growth and polyoma virus middle T function.
Talmage DA; Riney C; Benjamin TL
Cell Growth Differ; 1991 Jan; 2(1):51-8. PubMed ID: 1706618
[TBL] [Abstract][Full Text] [Related]
9. Erythroid differentiation and the cell cycle: some implications from murine foetal and erythroleukemic cells.
Rifkind RA; Marks PA; Bank A; Terada M; Maniatis GM; Reuben R; Fibach E
Ann Immunol (Paris); 1976; 127(6):887-93. PubMed ID: 1070288
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
11. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
12. An increase in the expression and total activity of endogenous p60(c-Src) in several factor-independent mutants of a human GM-CSF-dependent leukemia cell line (TF-1).
Horn S; Meyer J; Stocking C; Ostertag W; Jücker M
Oncogene; 2003 Oct; 22(46):7170-80. PubMed ID: 14562045
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
Gewirtz DA; Di X; Walker TD; Sawyer ST
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
[TBL] [Abstract][Full Text] [Related]
14. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
[TBL] [Abstract][Full Text] [Related]
15. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase.
Kubota Y; Tanaka T; Kitanaka A; Ohnishi H; Okutani Y; Waki M; Ishida T; Kamano H
EMBO J; 2001 Oct; 20(20):5666-77. PubMed ID: 11598010
[TBL] [Abstract][Full Text] [Related]
16. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
Tsuyuoka R; Takahashi T; Suzuki A; Sasaki Y; Nakamura K; Fukumoto M; Ohmori K; Ohno Y; Nakao K
Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
[TBL] [Abstract][Full Text] [Related]
17. A multifunctional 5-aminolevulinic acid derivative induces erythroid differentiation of K562 human erythroleukemic cells.
Berkovitch-Luria G; Yakobovitch S; Weitman M; Nudelman A; Rozic G; Rephaeli A; Malik Z
Eur J Pharm Sci; 2012 Aug; 47(1):206-14. PubMed ID: 22705251
[TBL] [Abstract][Full Text] [Related]
18. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
19. In vitro proliferation and differentiation of erythroid progenitors of cord blood.
Sakatoku H; Inoue S
Stem Cells; 1997; 15(4):268-74. PubMed ID: 9253110
[TBL] [Abstract][Full Text] [Related]
20. Activation and inhibition of the erythropoietin receptor by a membrane-anchored erythropoietin.
Negre O; Fusil F; Henri A; Villette JM; Leboulch P; Beuzard Y; Payen E
Exp Hematol; 2008 Apr; 36(4):412-23. PubMed ID: 18295963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]